You have 9 free searches left this month | for more free features.

City

Tempe (2)

Lincoln (1)

Condition

Metabolism and Nutrition Disorder (1)

Metabolism and Nutrition Disorders (1)

Obesity (1)

Overweight or Obesity (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 1 (2)

Sponsor

Novo Nordisk A/S (2)

Collaborator

Intervention

nnc0165-1562 (2)

placebo (1)

placebo (nnc0165-1562) (1)

semaglutide (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

nnc0165-1562

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Metabolism and Nutrition Disorders, Overweight or Obesity Trial in Tempe, Lincoln (NNC0165-1562, Semaglutide, Placebo

Completed

Metabolism and Nutrition Disorders
Overweight or Obesity

NNC0165-1562
+2 more

Tempe, Arizona
+1 more

Jul 1, 2021

Metabolism and Nutrition Disorder, Obesity Trial in Tempe (NNC0165-1562, )

Completed

Metabolism and Nutrition Disorder
Obesity

NNC0165-1562
placebo

Tempe, Arizona

Novo Nordisk Investigational Site

Jul 12, 2018